Unlike wild-type cells, clones expressing CRT mutants induced elevated levels of soluble CRT, leading to an expansion of MDSCs in the spleen and in peripheral blood in different tumor mouse models, with the consequent failure of anti-tumor treatment (232). This evidence concerns the gene CALR and neoplasm.